Skip to content

Nxstage Pureflow-B Solution

by NxStage Medical, Inc.

510(k) K042045

Nxstage Pureflow-B Solution is a medical device (FDA Class II; FDA product code KPO, Dialysate Concentrate For Hemodialysis (Liquid Or Powder)) made by NxStage Medical, Inc., cleared under FDA 510(k) K042045 on 27 Aug 2004, active as of 11 Oct 2026. One FDA recall is linked to it.

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None ongoing

1 closed

Documents

Trust

Unverified

Source FDA 510(k), synced 11 Oct 2026.

Regulatory status

as of registry sync 11 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Special NumberK042045 Date27 Aug 2004ClearedStatusActive

Official records

From the FDA record

Received by the FDA
30 Jul 2004
FDA decision
27 Aug 2004 (Substantially Equivalent)
FDA review time
28 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K042045 (openFDA), as read on 11 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Recalls

1 recall · FDA

    • Terminated Z-1214-2013 FDA Class II initiated 18 Mar 2013

    Product may be mislabeled.

Timeline

2 dated events

  1. Cleared FDA 510(k) K042045
  2. Recall initiated FDA recalls Z-1214-2013

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
KPO
Device class
Class II
Regulation
21 CFR Part 876.5820
Advisory committee
Gastroenterology, Urology
FDA decision
SESE Substantially Equivalent

Similar devices

Other devices filed under FDA product code KPO (Dialysate Concentrate For Hemodialysis (Liquid Or Powder)).

Other devices from NxStage Medical, Inc.

See all devices from NxStage Medical, Inc. →